LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD Market Closed
Market Cap: 45.8m USD

LAVA Therapeutics NV
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

LAVA Therapeutics NV
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Total Equity
$28m
CAGR 3-Years
-38%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Total Equity
$265m
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
26%
ProQR Therapeutics NV
NASDAQ:PRQR
Total Equity
€57.1m
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-5%
Uniqure NV
NASDAQ:QURE
Total Equity
$228.7m
CAGR 3-Years
-18%
CAGR 5-Years
0%
CAGR 10-Years
5%
argenx SE
XBRU:ARGX
Total Equity
$5.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Total Equity
$774.9m
CAGR 3-Years
37%
CAGR 5-Years
56%
CAGR 10-Years
35%
No Stocks Found

LAVA Therapeutics NV
Glance View

Market Cap
45.8m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
2.52 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is LAVA Therapeutics NV's Total Equity?
Total Equity
28m USD

Based on the financial report for Dec 31, 2024, LAVA Therapeutics NV's Total Equity amounts to 28m USD.

What is LAVA Therapeutics NV's Total Equity growth rate?
Total Equity CAGR 5Y
37%

Over the last year, the Total Equity growth was -45%. The average annual Total Equity growth rates for LAVA Therapeutics NV have been -38% over the past three years , 37% over the past five years .

Back to Top